Determinants of recurrence after intended curative resection for colorectal cancer

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Mitry E, Barthod F, Penna C, Nordlinger B. Surgery for colon and rectal cancer. Best Pract Res Clin Gastroenterol 2002;16:253–65.
   PubMed Web of Science ®Google Scholar
• Biondo S, Marti-Rague J, Kreisler E, Pares D, Martin A, Navarro M, et al. A prospective study of outcomes of emergency and elective surgeries for complicated colonic cancer. Am J Surg 2005;189:377–83.
   PubMed Web of Science ®Google Scholar
• Charbonnet P, Gervaz P, Andres A, Bucher P, Konrad B, Morel P. Results of emergency Hartmann’s operation for obstructive or perforated left-sided colorectal cancer. World J Surg Oncol 2008;6:90.
   PubMed Web of Science ®Google Scholar
• Heald RJ. Local recurrence of rectal cancer. Dis Colon Rectum 1987;30:572.
   PubMed Web of Science ®Google Scholar
• Shanmugam C, Hines RB, Jhala NC, Katkoori VR, Zhang B, Posey JA Jr, et al. Evaluation of lymph node numbers for adequate staging of stage II and III colon cancer. J Hematol Oncol 2011;4:25.
   PubMed Web of Science ®Google Scholar
• Laubert T, Habermann JK, Hemmelmann C, Kleemann M, Oevermann E, Bouchard R, et al. Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas. BMC Gastroenterol 2012;12:24.
   PubMed Web of Science ®Google Scholar
• Park JS, Choi GS, Jun SH, Park SY, Kim HJ. Long-term outcomes after laparoscopic surgery versus open surgery for rectal cancer: a propensity score analysis. Ann Surg Oncol 2013;20(8):2633–40.
   PubMed Web of Science ®Google Scholar
• Cortet M, Grimault A, Cheynel N, Lepage C, Bouvier A, Faivre J. Patterns of recurrence of obstructing colon cancers after surgery for cure: a population-based study. Colorectal Dis 2013;15(9):1100–6.
   PubMed Web of Science ®Google Scholar
• Dube S, Heyen F, Jenicek M. Adjuvant chemotherapy in colorectal carcinoma: results of a meta-analysis. Dis Colon Rectum 1997;40:35–41.
   PubMed Web of Science ®Google Scholar
• Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2007:CD002200.
   Google Scholar
• Renehan AG, O’Dwyer ST. Surveillance after colorectal cancer resection. Lancet 2000;355:1095–6.
   PubMedGoogle Scholar
• Renehan AG, Egger M, Saunders MP, O’Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002;324:813.
   PubMed Web of Science ®Google Scholar
• Sturgeon CM, Duffy MJ, Stenman UH, Lilja H, Brunner N, Chan DW, et al. National academy of clinical biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. Clin Chem 2008;54:e11–79.
   PubMed Web of Science ®Google Scholar
• Duffy MJ, van DA, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, et al. Tumour markers in colorectal cancer: European group on tumour markers (EGTM) guidelines for clinical use. Eur J Cancer 2007;43:1348–60.
   PubMed Web of Science ®Google Scholar
• Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006;24:5313–27.
   PubMed Web of Science ®Google Scholar
• Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731–40.
   PubMed Web of Science ®Google Scholar
• van GW, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011;12:575–82.
   PubMed Web of Science ®Google Scholar
• Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006;24:4620–5.
   PubMed Web of Science ®Google Scholar
• Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 2002;7:492–508.
   PubMed Web of Science ®Google Scholar
• Siegel R, Burock S, Wernecke KD, Kretzschmar A, Dietel M, Loy V, et al. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin cancer society. BMC Cancer 2009;9:50.
   PubMed Web of Science ®Google Scholar
• Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215–23.
   PubMed Web of Science ®Google Scholar
• Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Late adverse effects of radiation therapy for rectal cancer - a systematic overview. Acta Oncol 2007;46:504–16.
   PubMed Web of Science ®Google Scholar
• Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish rectal cancer trial. J Clin Oncol 2005;23:8697–705.
   PubMed Web of Science ®Google Scholar
• Law WL, Chu KW, Ho JW, Tung HM, Law SY, Chu KM. Self-expanding metallic stent in the treatment of colonic obstruction caused by advanced malignancies. Dis Colon Rectum 2000;43:1522–7.
   PubMed Web of Science ®Google Scholar
• Lacy AM, Garcia-Valdecasas JC, Pique JM, Delgado S, Campo E, Bordas JM, et al. Short-term outcome analysis of a randomized study comparing laparoscopic vs open colectomy for colon cancer. Surg Endosc 1995;9:1101–5.
   PubMed Web of Science ®Google Scholar
• Lacy AM, Garcia-Valdecasas JC, Delgado S, Castells A, Taura P, Pique JM, et al. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 2002;359:2224–9.
   PubMed Web of Science ®Google Scholar
• Green BL, Marshall HC, Collinson F, Quirke P, Guillou P, Jayne DG, et al. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg 2013;100:75–82.
   PubMed Web of Science ®Google Scholar
• Biondo S, Kreisler E, Millan M, Fraccalvieri D, Golda T, Frago R, et al. Impact of surgical specialization on emergency colorectal surgery outcomes. Arch Surg 2010;145:79–86.
   PubMedGoogle Scholar
• Jullumstro E, Wibe A, Lydersen S, Edna TH. Colon cancer incidence, presentation, treatment and outcomes over 25 years. Colorectal Dis 2011;13:512–18.
   PubMed Web of Science ®Google Scholar
• Meisner S, Gonzalez-Huix F, Vandervoort JG, Goldberg P, Casellas JA, Roncero O, et al. Self-expandable metal stents for relieving malignant colorectal obstruction: short-term safety and efficacy within 30 days of stent procedure in 447 patients. Gastrointest Endosc 2011;74:876–84.
   PubMed Web of Science ®Google Scholar
• Hermanek P, Hohenberger W. The importance of volume in colorectal cancer surgery. Eur J Surg Oncol 1996;22:213–15.
   PubMed Web of Science ®Google Scholar
• Hermanek P. Impact of surgeon’s technique on outcome after treatment of rectal carcinoma. Dis Colon Rectum 1999;42:559–62.
   PubMed Web of Science ®Google Scholar
• Hohenberger W. Quality criteria of surgical treatment of rectal carcinoma: preservation of continence, and local recurrence. G Chir 1998;19:197–8.
   PubMedGoogle Scholar
• Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 2009;373:821–8.
   PubMed Web of Science ®Google Scholar
• Quirke P. Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet Oncol 2003;695–702.
   PubMed Web of Science ®Google Scholar
• Frago R, Ramirez E, Millan M, Kreisler E, del VE, Biondo S. Current management of acute malignant large bowel obstruction: a systematic review. Am J Surg 2014;207:127–38.
   PubMed Web of Science ®Google Scholar
• Sommeling CA, Haeck L. Caecostomy in the management of acute left colonic obstruction. Acta Chir Belg 1997;97:217–19.
   PubMed Web of Science ®Google Scholar
• Gorissen KJ, Tuynman JB, Fryer E, Wang L, Uberoi R, Jones OM, et al. Local recurrence after stenting for obstructing left-sided colonic cancer. Br J Surg 2013;100:1805–9.
   PubMed Web of Science ®Google Scholar
• Petersen S, Freitag M, Hellmich G, Ludwig K. Anastomotic leakage: impact on local recurrence and survival in surgery of colorectal cancer. Int J Colorectal Dis 1998;13:160–3.
   PubMed Web of Science ®Google Scholar
• Krarup PM, Nordholm-Carstensen A, Jorgensen LN, Harling H. Anastomotic leak increases distant recurrence and long-term mortality after curative resection for colonic cancer: a nationwide cohort study. Ann Surg 2014;259:930–8.
   PubMed Web of Science ®Google Scholar
• Definition of disease free survival. 2013. Available from: http://www.cancer.gov/dictionary?cdrid=44023.
   Google Scholar
• Poon JT, Cheung CW, Fan JK, Lo OS, Law WL. Single-incision versus conventional laparoscopic colectomy for colonic neoplasm: a randomized, controlled trial. Surg Endosc 2012;26:2729–34.
   PubMed Web of Science ®Google Scholar
• Atallah S, Albert M, Larach S. Transanal minimally invasive surgery: a giant leap forward. Surg Endosc 2010;24:2200–5.
   PubMed Web of Science ®Google Scholar
• Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986;1:1479–82.
   PubMed Web of Science ®Google Scholar
• Heald RJ. The ’Holy Plane’ of rectal surgery. J R Soc Med 1988;81:503–8.
   PubMed Web of Science ®Google Scholar
• Heald RJ, MacFarlane JK, Ryall RD. Surgical lateral clearance in resected rectal carcinomas: a multivariate analysis of clinicopathologic features. Cancer 1993;72:1806.
   PubMed Web of Science ®Google Scholar
• Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998;133:894–9.
   PubMed Web of Science ®Google Scholar
• Heald RJ, Moran BJ. Embryology and anatomy of the rectum. Semin Surg Oncol 1998;15:66–71.
   PubMedGoogle Scholar
• Heald RJ. Total mesorectal excision (TME). Acta Chir Iugosl 2000;47:17–18.
   PubMedGoogle Scholar
• Heald RJ, Moran BJ, Brown G, Daniels IR. Optimal total mesorectal excision for rectal cancer is by dissection in front of Denonvilliers’ fascia. Br J Surg 2004;91:121–3.
   PubMed Web of Science ®Google Scholar
• Kim NK, Baik SH, Seong JS, Kim H, Roh JK, Lee KY, et al. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival. Ann Surg 2006;244:1024–30.
   PubMed Web of Science ®Google Scholar
• Kim SH, Bae KB, Kim JM, Shin JH, An MS, Ha TG, et al. Oncologic Outcomes and risk factors for recurrence after tumor-specific mesorectal excision of rectal cancer: 782 cases. J Korean Soc Coloproctol 2012;28:100–7.
   PubMedGoogle Scholar
• Gosens MJ, Klaassen RA, Tan-Go I, Rutten HJ, Martijn H, van den Brule AJ, et al. Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma. Clin Cancer Res 2007;13:6617–23.
   PubMed Web of Science ®Google Scholar
• Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002;26:350–7.
   PubMed Web of Science ®Google Scholar
• Ptok H, Ruppert R, Stassburg J, Maurer CA, Oberholzer K, Junginger T, et al. Pretherapeutic MRI for decision-making regarding selective neoadjuvant radiochemotherapy for rectal carcinoma: interim analysis of a multicentric prospective observational study. J Magn Reson Imaging 2013;37:1122–8.
   PubMed Web of Science ®Google Scholar
• Hohenberger W, Meyer T. [Basic principles in surgical oncology (2)]. Zentralbl Chir 2000;125:W39–48.
   Web of Science ®Google Scholar
• Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation–technical notes and outcome. Colorectal Dis 2009;11:354–64.
   PubMed Web of Science ®Google Scholar
• Hohenberger W, Reingruber B, Merkel S. Surgery for colon cancer. Scand J Surg 2003;92:45–52.
   PubMedGoogle Scholar
• Gouvas N, Tsiaoussis J, Pechlivanides G, Tzortzinis A, Dervenis C, Avgerinos C, et al. Quality of surgery for rectal carcinoma: comparison between open and laparoscopic approaches. Am J Surg 2009;198:702–8.
   PubMed Web of Science ®Google Scholar
• Gouvas N, Pechlivanides G, Zervakis N, Kafousi M, Xynos E. Complete mesocolic excision in colon cancer surgery: a comparison between open and laparoscopic approach. Colorectal Dis 2012;14:1357–64.
   PubMed Web of Science ®Google Scholar
• Hunter JA, Ryan JA Jr, Schultz P. En bloc resection of colon cancer adherent to other organs. Am J Surg 1987;154:67–71.
   PubMed Web of Science ®Google Scholar
• Wiggers T, Jeekel J, Arends JW, Brinkhorst AP, Kluck HM, Luyk CI, et al. No-touch isolation technique in colon cancer: a controlled prospective trial. Br J Surg 1988;75:409–15.
   PubMed Web of Science ®Google Scholar
• Quirke P, Risio M, Lambert R, von KL, Vieth M. Quality assurance in pathology in colorectal cancer screening and diagnosis-European recommendations. Virchows Arch 2011;458:1–19.
   PubMed Web of Science ®Google Scholar
• Saha S. Use of tumor size to predict long-term survival in colon cancer patients: Analysis of National Cancer Data Base (NCDB). J Clin Oncol 2013;31(suppl): abstract 3583.
   Google Scholar
• Weiss JM, Pfau PR, O’Connor ES, King J, LoConte N, Kennedy G, et al. Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results–Medicare data. J Clin Oncol 2011;29:4401–9.
   PubMed Web of Science ®Google Scholar
• Jess P, Hansen IO, Gamborg M, Jess T. A nationwide Danish cohort study challenging the categorisation into right-sided and left-sided colon cancer. BMJ Open 2013;3(5). pii: e002608. doi: 10.1136/bmjopen-2013-002608.
   PubMed Web of Science ®Google Scholar
• Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 2010;53:57–64.
   PubMed Web of Science ®Google Scholar
• Diculescu M, Iacob R, Iacob S, Croitoru A, Becheanu G, Popeneciu V. The importance of histopathological and clinical variables in predicting the evolution of colon cancer. Rom J Gastroenterol 2002;11:183–9.
   PubMedGoogle Scholar
• Halvorsen TB, Seim E. Tumour site: a prognostic factor in colorectal cancer? A multivariate analysis. Scand J Gastroenterol 1987;22:124–8.
   PubMed Web of Science ®Google Scholar
• Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003;10:65–71.
   PubMed Web of Science ®Google Scholar
• Huh JW, Kim CH, Lim SW, Kim HR, Kim YJ. Early recurrence in patients undergoing curative surgery for colorectal cancer: is it a predictor for poor overall survival? Int J Colorectal Dis 2013;28:1143–9.
   PubMed Web of Science ®Google Scholar
• Broll R, Schauer V, Schimmelpenning H, Strik M, Woltmann A, Best R, et al. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study. Dis Colon Rectum 1997;40:1465–71.
   PubMed Web of Science ®Google Scholar
• Derwinger K, Gustavsson B. A study of lymph node ratio in stage IV colorectal cancer. World J Surg Oncol 2008;6:127.
   PubMed Web of Science ®Google Scholar
• Doekhie FS, Mesker WE, Kuppen PJ, van Leeuwen GA, Morreau H, de Bock GH, et al. Detailed examination of lymph nodes improves prognostication in colorectal cancer. Int J Cancer 2010;126:2644–52.
   PubMed Web of Science ®Google Scholar
• Doekhie FS, Peeters KC, Kuppen PJ, Mesker WE, Tanke HJ, Morreau H, et al. The feasibility and reliability of sentinel node mapping in colorectal cancer. Eur J Surg Oncol 2005;31:854–62.
   PubMed Web of Science ®Google Scholar
• Liefers GJ, Cleton-Jansen AM, van de Velde CJ, Hermans J, van Krieken JH, Cornelisse CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223–8.
   PubMed Web of Science ®Google Scholar
• Lips DJ, Koebrugge B, Liefers GJ, van de Linden JC, Smit VT, Pruijt HF, et al. The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute plus sign in circle Study. BMC Surg 2011;11:11.
   PubMed Web of Science ®Google Scholar
• Quirke P, Palmer T, Hutchins GG, West NP. Histopathological work-up of resection specimens, local excisions and biopsies in colorectal cancer. Dig Dis 2012;30:2–8.
   PubMed Web of Science ®Google Scholar
• Derwinger K, Carlsson G, Gustavsson B. A study of lymph node ratio as a prognostic marker in colon cancer. Eur J Surg Oncol 2008;34:771–5.
   PubMed Web of Science ®Google Scholar
• van der Zaag ES, Buskens CJ, Kooij N, Akol H, Peters HM, Bouma WH, et al. Improving staging accuracy in colon and rectal cancer by sentinel lymph node mapping: a comparative study. Eur J Surg Oncol 2009;35:1065–70.
   PubMed Web of Science ®Google Scholar
• Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 2009;27:5131–7.
   PubMed Web of Science ®Google Scholar
• Peng J, Sheng W, Huang D, Venook AP, Xu Y, Guan Z, et al. Perineural invasion in pT3N0 rectal cancer: the incidence and its prognostic effect. Cancer 2011;117:1415–21.
   PubMed Web of Science ®Google Scholar
• Tsai HL, Chu KS, Huang YH, Su YC, Wu JY, Kuo CH, et al. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol 2009;100:736–43.
   PubMed Web of Science ®Google Scholar
• Huh JW, Lee JH, Kim HR, Kim YJ. Prognostic significance of lymphovascular or perineural invasion in patients with locally advanced colorectal cancer. Am J Surg 2013;206:758–63.
   PubMed Web of Science ®Google Scholar
• Tsai HL, Cheng KI, Lu CY, Kuo CH, Ma CJ, Wu JY, et al. Prognostic significance of depth of invasion, vascular invasion and numbers of lymph node retrievals in combination for patients with stage II colorectal cancer undergoing radical resection. J Surg Oncol 2008;97:383–7.
   PubMed Web of Science ®Google Scholar
• Betge J, Pollheimer MJ, Lindtner RA, Kornprat P, Schlemmer A, Rehak P, et al. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer 2012;118:628–38.
   PubMed Web of Science ®Google Scholar
• Tsujimoto H, Ueno H, Hashiguchi Y, Ono S, Ichikura T, Hase K. Postoperative infections are associated with adverse outcome after resection with curative intent for colorectal cancer. Oncol Lett 2010;1:119–25.
   PubMed Web of Science ®Google Scholar
• Ytting H, Christensen IJ, Jensenius JC, Thiel S, Nielsen HJ. Preoperative mannan-binding lectin pathway and prognosis in colorectal cancer. Cancer Immunol Immunother 2005;54:265–72.
   PubMed Web of Science ®Google Scholar
• Krarup PM, Jorgensen LN, Andreasen AH, Harling H. A nationwide study on anastomotic leakage after colonic cancer surgery. Colorectal Dis 2012;14:e661–7.
   Web of Science ®Google Scholar
• Mynster T. Blood transfusion-induced immunomodulation–is storage time important? Dan Med Bull 2003;50:368–84.
   PubMedGoogle Scholar
• Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006:CD005033.
   Google Scholar
• Blumberg N, Agarwal MM, Chuang C. Relation between recurrence of cancer of the colon and blood transfusion. Br Med J (Clin Res Ed) 1985;290:1037–9.
   PubMed Web of Science ®Google Scholar
• Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 colorectal cancer study group. Br J Surg 2000;87:1553–62.
   PubMed Web of Science ®Google Scholar
• Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y, Kusunoki M. Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol (R Coll Radiol) 2006;18:60–6.
   PubMed Web of Science ®Google Scholar
• Nielsen HJ. Influence on the immune system of homologous blood transfusion and autologous blood donation: impact on the routine clinical practice/differences in oncological and non-tumour surgery? Anasthesiol Intensivmed Notfallmed Schmerzther 2000;35:642–5.
   PubMed Web of Science ®Google Scholar
• Birgisson H, Ghanipour A, Smedh K, Pahlman L, Glimelius B. The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer. Fam Cancer 2009;8:555–61.
   PubMed Web of Science ®Google Scholar
• Chan JA, Meyerhardt JA, Niedzwiecki D, Hollis D, Saltz LB, Mayer RJ, et al. Association of family history with cancer recurrence and survival among patients with stage III colon cancer. JAMA 2008;299:2515–23.
   PubMed Web of Science ®Google Scholar
• Bertagnolli MM, Redston M, Compton CC, Niedzwiecki D, Mayer RJ, Goldberg RM, et al. Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer–a study of CALGB 9581 and 89803. J Clin Oncol 2011;29:3153–62.
   PubMed Web of Science ®Google Scholar
• Finkelstein SD, Sayegh R, Christensen S, Swalsky PA. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer 1993;71:3827–38.
   PubMed Web of Science ®Google Scholar
• Finkelstein SD, Sayegh R, Bakker A, Swalsky P. Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg 1993;128:526–31.
   PubMed Web of Science ®Google Scholar
• Bleeker WA, Hayes VM, Karrenbeld A, Hofstra RM, Verlind E, Hermans J, et al. Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancer. Dis Colon Rectum 2001;44:358–63.
   PubMed Web of Science ®Google Scholar
• Petersen SH, Harling H, Kirkeby LT, Wille-Jorgensen P, Mocellin S. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev 2012;3:CD004078.
   PubMed Web of Science ®Google Scholar
• Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. Lancet 2007;370:2020–9.
   PubMed Web of Science ®Google Scholar
• Lee DW. Molecular characteristics and prognostic implication of mucious histology in colorectal cancer patients treated with adjuvant FOLFOX. J Clin Oncol 2013;31(suppl): abstract 3550.
   Google Scholar
• Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51.
   PubMed Web of Science ®Google Scholar
• Kuebler JP, Wieand HS, O’Connell MJ, Smith RE, Colangelo LH, Yothers G, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007;25:2198–204.
   PubMed Web of Science ®Google Scholar
• Wilkinson NW, Yothers G, Lopa S, Costantino JP, Petrelli NJ, Wolmark N. Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials. Ann Surg Oncol 2010;17:959–66.
   PubMed Web of Science ®Google Scholar
• Boisen MK, Johansen JS, Dehlendorff C, Larsen JS, Osterlind K, Hansen J, et al. Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer. Ann Oncol 2013;24:2554–9.
   PubMed Web of Science ®Google Scholar
• Boisen MK. Primary tumor location and expression of mir-664 as a combined biomarker for bevacizumab effectiveness in metastatic colorectal cancer. J Clin Oncol 2013;31(suppl): abstract 3572.
   Google Scholar
• McCleary NJ, Meyerhardt JA, Green E, Yothers G, de GA, Van CE, et al. Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT Database. J Clin Oncol 2013;31:2600–6.
   PubMed Web of Science ®Google Scholar
• Glimelius B, Dahl O, Cedermark B, Jakobsen A, Bentzen SM, Starkhammar H, et al. Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic gastrointestinal tumour adjuvant therapy group. Acta Oncol 2005;44:904–12.
   PubMed Web of Science ®Google Scholar
• Hafstrom L, Domellof L, Rudenstam CM, Norryd C, Bergman L, Nilsson T, et al. Adjuvant chemotherapy with 5-fluorouracil, vincristine and CCNU for patients with Dukes’ C colorectal cancer. The Swedish gastrointestinal tumour adjuvant therapy group. Br J Surg 1990;77:1345–8.
   PubMed Web of Science ®Google Scholar
• Kodaira S. Postoperative adjuvant chemotherapy with mitomycin C and UFT for curatively resected rectal cancer. Results from the cooperative project No.7 Group of the Japanese foundation for multidisciplinary treatment of cancer. Int J ClinOncol 2013;31(suppl): abstract 3644.
   Google Scholar
• Lievre A, Bachet JB, Boige V, Cayre A, Le CD, Buc E, et al. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab. J Clin Oncol 2008;26:374–9.
   PubMed Web of Science ®Google Scholar
• Birgisson H, Nielsen HJ, Christensen IJ, Glimelius B, Brunner N. Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: a prospective validation study. Eur J Cancer 2010;46:3323–31.
   PubMed Web of Science ®Google Scholar
• Nielsen HJ, Christensen IJ, Brunner N. A novel prognostic index in colorectal cancer defined by serum carcinoembryonic antigen and plasma tissue inhibitor of metalloproteinases-1. Scand J Gastroenterol 2010;45:200–7.
   PubMed Web of Science ®Google Scholar
• Holten-Andersen MN, Nielsen HJ, Sorensen S, Jensen V, Brunner N, Christensen IJ. Tissue inhibitor of metalloproteinases-1 in the postoperative monitoring of colorectal cancer. Eur J Cancer 2006;42:1889–96.
   PubMed Web of Science ®Google Scholar
• Bertagnolli MM, Redston M, Compton CC, Niedzwiecki D, Mayer RJ, Goldberg RM, et al. Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer–a study of CALGB 9581 and 89803. J Clin Oncol 2011;29:3153–62.
   PubMed Web of Science ®Google Scholar
• Tougeron D. Prognostic factors of recurrence of colorectal cancers with microsatellite instability after curative resection: an AGEO retrospective multicenter study. J Clin Oncol 2013;31(suppl): abstract 3536.
   Google Scholar
• Mouliere F, El MS, Gongora C, Guedj AS, Robert B, Del RM, et al. Circulating cell-free DNA from colorectal cancer patients may reveal high KRAS or BRAF mutation load. Transl Oncol 2013;6:319–28.
   PubMed Web of Science ®Google Scholar
• Nielsen BS, Jorgensen S, Fog JU, Sokilde R, Christensen IJ, Hansen U, et al. High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 2011;28:27–38.
   PubMed Web of Science ®Google Scholar
• Bro R, Nielsen HJ, Savorani F, Kjeldahl K, Christensen IJ, Brunner N, et al. Data fusion in metabolomic cancer diagnostics. Metabolomics 2013;9:3–8.
   PubMed Web of Science ®Google Scholar
• Levy M, Benesova L, Lipska L, Belsanova B, Minarikova P, Veprekova G, et al. Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients. Anticancer Res 2012;32:1621–6.
   PubMed Web of Science ®Google Scholar
• Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. PLoS Med 2012;9:e1001216.
   PubMed Web of Science ®Google Scholar
• Mallett S, Timmer A, Sauerbrei W, Altman DG. Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines. Br J Cancer 2010;102:173–80.
   PubMed Web of Science ®Google Scholar